Comparison

ZM 449829 European Partner

Item no. HY-13450-10mg
Manufacturer MedChem Express
CASRN 4452-06-6
Amount 10 mg
Quantity options 10 mg 25 mg 5 mg
Category
Type Standard
Specific against other
Purity 99.73
Citations [1]Brown GR, et, al. Naphthyl ketones: a new class of Janus kinase 3 inhibitors. Bioorg Med Chem Lett. 2000 Mar 2010(6)575-9.|[2]Orange JS, et, al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest. 2011 Apr; 121(4): 1535-48.
Smiles C=CC(C1=CC=C2C=CC=CC2=C1)=O
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
EGFR; JAK
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
182.22
Product Description
ZM 449829 is a potent, selective and ATP competitive inhibitor of JAK3, with a pIC50 of 6.8. ZM 449829 will be useful pharmacological tools for the investigation of the JAK3[1].
Manufacturer - Research Area
Inflammation/Immunology
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturer - Pathway
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Clinical information
No Development Reported
Isoform
EGFR/ErbB1/HER1; JAK1; JAK3

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close